Strata Skin Sciences, Inc.
SSKN
$0.14
$0.014.37%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -8.54% | -5.19% | 0.36% | 3.30% | 0.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.54% | -5.19% | 0.36% | 3.30% | 0.61% |
| Cost of Revenue | -10.45% | -9.99% | -7.19% | -9.39% | -2.96% |
| Gross Profit | -7.09% | -1.34% | 6.68% | 14.69% | 3.49% |
| SG&A Expenses | 0.73% | 1.04% | 10.72% | 2.33% | -1.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.38% | -4.43% | 2.20% | -3.64% | -2.82% |
| Operating Income | 2.20% | 0.39% | -13.87% | 37.75% | 20.93% |
| Income Before Tax | 36.95% | -19.53% | -39.42% | 18.55% | 6.01% |
| Income Tax Expenses | 107.06% | -84.78% | -84.78% | -84.78% | -84.78% |
| Earnings from Continuing Operations | 35.77% | -18.89% | -38.92% | 19.39% | 6.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.77% | -18.89% | -38.92% | 19.39% | 6.78% |
| EBIT | 2.20% | 0.39% | -13.87% | 37.75% | 20.93% |
| EBITDA | 296.55% | -41.16% | -1,292.50% | 167.00% | 96.22% |
| EPS Basic | 40.94% | -1.84% | -17.32% | 31.77% | 16.35% |
| Normalized Basic EPS | 12.30% | 18.25% | 9.62% | 37.30% | 16.08% |
| EPS Diluted | 41.22% | -1.84% | -17.32% | 31.77% | 16.35% |
| Normalized Diluted EPS | 12.30% | 18.25% | 9.62% | 37.30% | 16.08% |
| Average Basic Shares Outstanding | 22.16% | 16.79% | 18.20% | 13.60% | 9.00% |
| Average Diluted Shares Outstanding | 22.16% | 16.79% | 18.20% | 13.60% | 9.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |